The widespread availability of programmable site-specific nucleases now enables targeted gene disruption in the zebrafish. In this study, we applied site-specific nucleases to generate zebrafish lines bearing individual mutations in more than twenty genes. We found that mutations in only a small proportion of genes caused defects in embryogenesis. Moreover, mutants for ten different genes failed to recapitulate published Morpholino-induced phenotypes (morphants). The absence of phenotypes in mutant embryos was not likely due to maternal effects or failure to eliminate gene function. Consistently, a comparison of published morphant defects with the Sanger Zebrafish Mutation Project revealed that approximately eighty percent of morphant phenotypes were not observed in mutant embryos, similar to our mutant collection. Based on these results, we
INTRODUCTION
The zebrafish has become a central model system to investigate vertebrate development. Early foundational studies utilized zebrafish in large-scale forward genetic screens to identify mutants affecting different aspects of embryonic development (Driever et al., 1996; Haffter et al., 1996) . These studies took advantage of the many benefits of zebrafish husbandry and embryogenesis. In particular, rapid external development of the transparent zebrafish embryo allowed detection of a range of mutant phenotypes during development. The hardy nature of zebrafish adults and their ability to produce large clutch sizes facilitated subsequent mapping of causative mutant genes (Lawson and Wolfe, 2011) . These genetic screens based simply on observing embryonic morphology resulted in the discovery of genes required for distinct steps in embryogenesis, including gastrulation , cardiovascular morphogenesis , and hematopoiesis (Ransom et al., 1996) . Subsequent forward genetic screens have been applied to dissect an array of different biological processes, ranging from immunity to digestion (Lawson and Wolfe, 2011) . This work demonstrates the broad and powerful impact that the zebrafish has had as a genetic model system across multiple fields of study.
Despite the utility of forward genetics, screening to saturation in the zebrafish is challenging (Lawson and Wolfe, 2011) . At the same time, the deluge of sequence data over the past decade has revealed a wealth of genes for which no mutations currently exist in zebrafish. Thus, there is a need for reverse genetic approaches to assess gene function. While not a true genetic approach, the introduction of antisense Morpholino oligomers (MOs) was initially greeted with excitement in the zebrafish community as a tool to interrogate gene function. MOs differ from standard nucleic acid oligonucleotides in that they possess a 6-ring heterocycle backbone and non-ionic phosphorodiamidate linkages (Summerton and Weller, 1997) . These modifications make MOs highly stable in vivo, allow them to have a high affinity for RNA, and supposedly reduce their off-target binding to macromolecules (Summerton, 2007) . MOs can be designed to block translation or splicing and their injection into 1-cell stage zebrafish embryos can recapitulate known mutant phenotypes (Draper et al., 2001; Nasevicius and Ekker, 2000) . MOs can also block microRNA maturation and their binding to target 3' untranslated regions (UTRs; Choi et al., 2007; Kloosterman et al., 2007) . Thus, MOs provide in principle an accessible and straightforward method for gene knockdown in the zebrafish embryo.
unknown. Despite this issue, anecdotal claims suggests that MOs do not share the same problems with off-target effects associated with other antisense technology, such as phosphorothioate-modified oligonucleotides (Summerton, 2007) . However, there has been little empirical research in this area.
Fortunately, definitive reverse genetic approaches in zebrafish have recently become available. In particular, programmable site-specific nucleases now enable targeted gene disruption in the zebrafish. Initial work utilized zinc finger nucleases (ZFNs; Doyon et al., 2008; Meng et al., 2008) and Transcription activator-like effector nucleases (TALENs), which provide improved specificity over ZFNs, have also been developed (Cade et al., 2012) . In both cases, mRNAs encoding ZFN or TALEN heterodimers are injected into 1-cell stage embryos, where they bind to their target and induce a double strand break. Imprecise repair of this break by non-homologous end joining introduces small insertions or deletions that can lead to a frameshift when targeting coding sequence; in a proportion of the embryos such lesions will occur within the germline. More recently, the programmable bacterial nuclease Cas9 has been successfully applied to introduce heritable lesions in the zebrafish genome at high frequency (Hwang et al., 2013) . Together, these tools provide a robust means to generate zebrafish bearing targeted mutations in genes of interest.
A number of groups, including our own, have put significant effort toward the development and application of site-specific nucleases in zebrafish (Bedell et al., 2012; Cade et al., 2012; Chen et al., 2013; Dahlem et al., 2012; Gupta et al., 2012; Gupta et al., 2013; Hwang et al., 2013; Sander et al., 2011; Zhu et al., 2011) . However, the systematic analysis of phenotypes in derived lines has lagged. In this study, we generated and characterized mutant lines for more than twenty genes. We find that the majority of these genes are dispensable for embryonic development. We also did not observe previously published MO-induced (morphant) phenotypes in ten mutant lines. A broader comparison of all published morphant phenotypes with the Sanger Zebrafish Mutation Project revealed similar discrepancies. Taken together, these observations suggest that MO off-target effects are much more prevalent than previously stated. Our results highlight the need to reevaluate the use of antisense-based technology for characterization of gene function in the zebrafish and emphasize the importance of applying targeted gene disruption for this purpose.
RESULTS

Generation of mutants in candidate genes of interest
Our general goal was to identify novel functions for genes involved in embryonic vascular development. For this purpose we applied programmable site-specific nucleases to introduce targeted deletions in candidate genes of interest identified from a number of sources (Table  S1 ). For the most part, candidate genes were expressed in endothelial cells based on published studies, available in situ hybridization data at the Zebrafish Information Network (ZFIN), or identified through our own unpublished work (Table S1 and data not shown). Fourteen genes had been targeted by MOs in published work and shown to cause a developmental phenotype, including 10 that displayed a vascular or lymphatic defect (amot, ccbe1, elmo1, ets1, flt4, fmnl3, gata2a, mmp2, nrp1a, pdgfrb ; Table S1 ). We have previously reported vascular defects in the gata2a mutant (Zhu et al., 2011) and it is included here as the first mutant generated in our knockout pipeline. We also included ccbe1 and flt4 as "positive control" target genes for which vascular defects have already been reported in mutants from forward genetic screens (Hogan et al., 2009a; Hogan et al., 2009b) .
We applied ZFNs, TALENs and, in one case, Cas9, to target genomic sequence that harbored a restriction site that could be used for genotyping and encoded amino acids in the amino-terminal half of a protein (Table S2 , see below, and data not shown). We did not target near the annotated start codon to avoid alternative translational start sites, except when targeting a signal peptide (e.g. ccbe1, mmp2). We identified founder fish bearing small insertions or deletions in their germline that introduced a frameshift into the coding sequence or eliminated a splice site ( Table S2 ). All of the lesions are expected to truncate the protein and cause non-sense mediated decay (NMD) of the mRNA transcript (see below; Table S2 ). For the linc:birc6 locus, we generated a large segmental deletion. In total, we generated mutant lines bearing thirty-two distinct lesions in twenty-four genes ( Table S2 ).
Lack of embryonic defects and discrepancy with morphant vascular phenotypes
We performed all phenotypic analysis on embryos derived from multiple in-crosses of identified heterozygous carriers of a respective mutation. In most cases, we generated families of heterozygous carriers by crossing founders with adults bearing endothelial or lymphatic endothelial transgenes to visualize vascular or lymphatic morphology, respectively (see below). We screened embryos for overt defects between 24 hours post fertilization (hpf) and 5 dpf. In parallel, we observed vascular morphology in transgenic embryos, and screened for abnormal circulatory patterns, loss of circulation, and evidence of hemorrhage. Following 5 dpf, we genotyped embryos to confirm the presence of homozygous wild type, mutant and heterozygous progeny at the expected ratios. In all cases where embryos failed to exhibit phenotypes we were able to detect genotypically mutant embryos at the expected frequency (data not shown; see examples for ets1a, fam38a, and fmnl3 below).
In the course of phenotypic analysis, we observed defects caused by mutations in only three of the twenty-four genes. These included gata2a, ccbe1 and flt4 mutants, the latter two of which exhibited loss of the thoracic duct, a primitive lymphatic structure ( Figure 1A , B) as expected from previous studies (Hogan et al., 2009a; Hogan et al., 2009b) . flt4 mutant embryos also failed to form the primordial hindbrain channel and parachordal lymphangioblasts ( Figure 1B ). All other mutants displayed normal overall and vascular morphology, as well as circulatory function throughout the first 5 days of development ( Figure S1 ; Table S3 , data not shown). For example, within the embryonic trunk at 30 hours post fertilization (hpf), intersegmental vessels (ISV) have completed their sprouting from the dorsal aorta (DA) and begin to form the dorsal longitudinal anastomotic vessel (DLAV) in wild type siblings ( Figure 2A ). The formation of these vessels has been used to screen for genes required for angiogenesis (for examples, see Covassin et al., 2009; Isogai et al., 2003; Lawson and Weinstein, 2002) . We did not observe defects in vascular morphogenesis or circulatory function in any of the mutant embryos, including those bearing mutations in guanine nucleotide exchange factors (GEFs), such as arhgef9b, kalrnb, fgd5a, or prex2 ( Figure 2B , C, D; Table S3 ; data not shown), which are candidates for genes important for endothelial migration. Most strikingly, we failed to observe defects in embryos bearing mutations in genes previously shown to be required for ISV formation using MOs (Table 1;  Table S3 ). For example, individual MO knockdowns of fmnl3 and pdgfrb cause a block in ISV sprouting (Hetheridge et al., 2012; Wiens et al., 2010) . However, embryos mutant for fmnl3 um150 or pdgfrb um148 display ISV growth that is indistinguishable from wild type siblings (Figure 2A , E, F). Likewise, flt4 um203 mutants do not exhibit ISV stalling as we previously described in morphants (Covassin et al., 2006) , despite the presence of fully penetrant lymphatic defects ( Figure 1B ). We noted similar defects in an extracellular domain truncation allele as well (Table S2 , data not shown) and flt4 um203 mutants display significantly reduced transcript levels consistent with NMD ( Figure 1B ) similar to fmnl3 um150 ( Figure 2G ). RT-PCR analysis of genotypically verified heterozygous and fmnl3 um150 mutant sibling embryos ruled out exon skipping and confirmed that residual mRNA transcripts bore the mutant lesion ( Figure 2H , I). Likewise, pdgfrb transcript is reduced in pdgfrb um148 mutant embryos and Western blot analysis confirmed the absence of protein ( Figure 2J , K).
Embryos bearing mutations in amot, elmo1, and ets1 also displayed normal vascular patterning and circulatory function despite previous reports of defects in respective morphant embryos (Table S3 ; data not shown; Aase et al., 2007; Epting et al., 2010; Pham et al., 2007) . In the case of the ets1 um206 mutation, we detected transcripts missing exon 3, which contains the um206 deletion, in heterozygous and mutant embryos ( Figure 2L , M), while all remaining sequenced full-length transcripts bore the um206 deletion (data not shown). In ets1, exon 3 encodes the pointed domain, which is essential for transcriptional activation by upstream kinases, such as ERK1/2 (Seidel and Graves, 2002) . Thus, it is possible that ets1 um206 is a hypomorphic allele. We also find that embryos bearing a truncation mutation in neuropilin1a (nrp1a; Figure 3A ), a Vegf co-receptor also implicated in ISV patterning by previous studies using MO-mediated knockdown (Lee et al., 2002; Martyn and Schulte-Merker, 2004) , display normal vascular patterning and circulation in the trunk blood vessels ( Figure 3B , C). We did not investigate whether pik3cg or smox mutant embryos exhibited previously described morphant defects in blood cell development (Tijssen et al., 2011; Yoo et al., 2010) , although both appeared normal until 5 dpf and smox mutant zebrafish were viable to adulthood (data not shown). Thus, for seven of the candidate genes previously implicated in ISV sprouting using MO knockdown (amot, elmo1, ets1, flt4, fmnl3, nrp1a, and pdgfrb) , we failed to detect these defects in corresponding mutant embryos.
The discrepancies between morphant and mutant phenotypes may suggest that ISV sprouting is particularly sensitive to MO off-target effects. Therefore, we observed embryos bearing mutations in genes implicated in other aspects of development. Previous studies using MO-targeting have reported that matrix metalloproteinase 2 (mmp2) is required for development of the primitive lymphatic system in zebrafish (Detry et al., 2012) . We generated an allele (mmp2 hu10535 ) that produces a frameshift in the signal peptide and truncates the Mmp2 coding sequence ( Figure 3D ); a similar truncation in the signal peptide of ccbe1 recapitulates lymphatic defects associated with previously described ccbe1 alleles (Figure 1 ; Hogan et al., 2009a) . By 5 days post fertilization (dpf), zebrafish larvae normally display formation of the thoracic duct and intersegmental lymphatic vessels (ISLVs), labeled in this case by a flt4:mCitrine transgene, lying adjacent to intersegmental arteries expressing flt1:tdTomato ( Figure 3E ). In embryos mutant for mmp2 hu10535 we similarly observed normal TD and ISLV development at this stage ( Figure 3F ). These results are in conflict with previous observations in morphant embryos (Detry et al., 2012) and suggest that mmp2 may be dispensable for early lymphatic development in zebrafish.
Two of the mutant lines we generated were expected to display non-vascular phenotypes based on published morphant data. fam38a encodes the zebrafish homolog of Piezo1, a multi-pass transmembrane protein that functions as a mechanosensory channel (Coste et al., 2012; Kim et al., 2012b) . In zebrafish, knockdown of fam38a using a start codon MO causes early severe morphological defects, leading to speculation that maternal contribution is important for early development (Eisenhoffer et al., 2012) . Inducible knockdown at later stages using a caged MO leads to epidermal masses in the developing fin fold due to defects in cell extrusion (Eisenhoffer et al., 2012) . However, separate studies using both translational and splice-targeting MOs reported specific defects in red blood cell volume, similar to human patients bearing gain of function mutations in PIEZO1 (Faucherre et al., 2014) , but no overt defects. The fam38a um136 mutant is a frameshift leading to truncation of the Fam38a coding sequence at amino acid 361 ( Figure 4A ; Table S2 ). Consistent with NMD, we observe that fam38a transcript is reduced in fam38a um136 mutant embryos compared to wild type siblings ( Figure 4B , C). RT-PCR analysis of residual fam38a transcript from mutant embryos did not reveal exon skipping or presence of wild type transcripts ( Figure 4D -F). Interestingly, we noted a low frequency of deletions larger than the um136 lesion suggesting that this microdeletion affects splicing, although all deletions in the transcript resulted in a frameshift ( Figure 4G ). Despite the presence of this mutation, fin morphology was indistinguishable between wild type and fam38a um136 mutant sibling embryos at 72 hpf ( Figure 5H , I). Together with the discrepancies between published reports utilizing a translation-blocking MO, these results suggest that the overt gastrulation and fin defects from previous studies (Eisenhoffer et al., 2012) may have been due to off-target effects.
The mutants described above bear frameshifts and in selected cases we observe evidence of NMD or loss of protein. However, we have also noted exon skipping and possible effects on splicing. A more desirable strategy to generate a null allele would be to introduce a large deletion in a locus of interest. This approach would be particularly useful for deleting noncoding RNAs for which functional domains are difficult to identify. We have previously applied two pairs of TALENs targeting adjacent cis sequences to delete the locus encoding the long non-coding RNA linc:birc6, also referred to as megamind (Gupta et al., 2013; Ulitsky et al., 2011) . MO-mediated knockdown of megamind in zebrafish causes hydrocephaly, as indicated by inflation of hindbrain ventricles (Ulitsky et al., 2011) . We established a zebrafish line (megamind um209 ) bearing a segmental deletion that eliminated transcripts arising from the megamind locus, but did not affect the cyrano lncRNA or expression of eef1a1l1 mRNA (Figure 5A, B) . Despite the absence of megamind RNA in mutant embryos, they were morphologically indistinguishable from wild type ( Figure 5C,  D) . megamind um209 mutants were viable into adulthood and embryos derived from in-crosses of megamind um209 homozygous adults were normal ( Figure 5D ). Similar results were observed for a second independent deletion of the megamind locus (Table S2 , data not shown). The deletion in megamind um209 mutant embryos also removes the sequences targeted by published MOs (Figure 4A ; (Ulitsky et al., 2011) . Strikingly, injection of a previously described MO targeting megamind induces the appearance of inflated hindbrain ventricles in both wild type siblings and megamind um209 mutant embryos, despite the absence of the MO target site in the latter (Figure 5E, F) . In this case, the MO target sequence bears only modest homology to other megamind paralogs within the genome (68 and 76 percent). We would point out that similar phenotypes were observed with splice site MOs that would not be expected to target these other long non-coding RNAs (Ulitsky et al., 2011) . The MO would also not be expected to reduce expression of the related tuna long non-coding RNA that has recently been implicated in brain development in zebrafish (Lin et al., 2014) . Thus, these observations suggest that the previously reported megamind phenotype is likely due to MO off-target effects.
Evidence of a high false-positive rate for morphant phenotypes
Our results suggest that many morphant phenotypes are not recapitulated in mutant embryos. To assess how universal this finding might be we performed an integrative analysis of curated datasets available from ZFIN and the Sanger Zebrafish Mutation Project (ZMP), which has reported phenotypic analysis of mutant embryos for more than 700 genes . We identified 98 ZMP mutants for which morphant phenotypes have been published. We restricted analysis to overt morphant phenotypes that affected the whole embryo and would have been easily seen in the ZMP phenotyping pipeline. We further performed literature-based validation of ZFIN data and eliminated any ZMP mutants unlikely to affect protein function (Table S4 ) to yield 24 genes for comparison (Table S5) . Mutations in only 5 of these genes resulted in observable phenotypes that were largely consistent with MO knockdown experiments, while the rest did not ( Figure 6 , Table 1; Table  S5 ). We did not note any obvious pattern in effective dosage, rescue penetrance, p53 rescue, or other variable that predicted whether a MO would yield a discordant phenotype (Table  S3 , S5).
The discrepancies between morphants and mutants may be due to the use of a MO targeting the start codon, which blocks translation of maternal mRNAs, while mutant embryos derived from heterozygotes lack only zygotic gene function. Therefore, we took into account two additional datasets: 1. nature of MO target sequence (translation, which would block maternal transcript translation, versus splice-blocking, which would affect only zygotic transcripts) used in each published study and 2. available RNA-Seq data to assess candidate mRNA levels at the 2-cell stage. We also considered studies in which maternal effects have been ruled out in published studies (e.g. ptenb; Faucherre et al., 2008) , as well as transcript analysis and crosses of homozygous mutants in our own lines (see above; Table S3 ). After applying these restrictions, we identified 14 ZMP mutants and 12 in our collection where maternal contribution was unlikely (Table S3 , S5; flt4 is counted twice as it recapitulates lymphatic but not ISV defects). In these cases, 12 out of 14 Sanger mutants and 9 out of 12 of our mutants fail to exhibit published morphant phenotypes (Tables S3, S5; Figure 6 ). Thus, even when considering the maternal contribution, more than 70 percent of morphant phenotypes were not observed in respective mutants from two separate collections ( Figure 6 ).
DISCUSSION
The development of programmable site-specific nucleases for genome modification now enables reverse genetic approaches to be applied in model and non-model organisms. As an initial step to broadly apply these tools in zebrafish, we have used ZFNs, TALENs and the CRISPR system to generate a collection of lines bearing mutations in candidate genes of interest. Despite the expression of most of our candidate genes in endothelial cells at early embryonic stages of development and their homology to known functional molecules, we failed to observe any notable vascular defects in mutant embryos for most of the genes analyzed. In this regard, our findings are consistent with low rates of overt phenotypes in a recent characterization of nearly 1000 zebrafish mutant lines and suggest a high degree of redundancy is built into the zebrafish genome.
A more troubling finding from our work is the discrepancy between morphant and mutant phenotypes. Our integrative analysis of ZMP and ZFIN datasets shows a high rate of discrepancy even when taking into account maternal contribution. A caveat here is that we restricted analysis to overt phenotypes that are also the most likely phenotypes caused by MO off-target effects. Also, some ZMP point mutants may not be null alleles. Thus, the true false-positive rate may not be as high when considering more specific defects in null mutants. However, in our mutants, which mostly bore deletions resulting in frameshifts, we focused on subtle vascular defects in a sensitive transgenic background. We also observed evidence of NMD or loss of protein in selected mutants supporting the fact that many are likely null alleles, yet we still observed a high false-positive morphant phenotype rate. Consistent with these observations, recent studies have reported inconsistencies between morphants and mutants for individual genes, including phenotypes affecting lymphatic development (nr2f2, Aranguren et al., 2011; Swift et al., 2014; van Impel et al., 2014) , neuronal function (mfn2 and prp2, Chapman et al., 2013; Fleisch et al., 2013; Nourizadeh-Lillabadi et al., 2010; Vettori et al., 2011) , hindbrain patterning (gbx2, Kikuta et al., 2003; Su et al., 2014) , and lateral line development (tcf7, Aman et al., 2011) . Taken together with our broader findings here, these studies raise a major concern about relying solely on the application of MOs for primary characterization of gene function in the zebrafish.
Our results suggest that many morphant phenotypes may be due to off-target effects. The most striking is the megamind mutant, where we recapitulated the morphant phenotype in embryos lacking the MO target site. This is especially worrisome as megamind morphants could be rescued by co-injecting megamind RNA (Ulitsky et al., 2011) . Likewise, five out of twelve of the morphant phenotypes that we failed to observe in mutants were rescued in previous studies (Table S3 ). Similar observations have recently been made for zebrafish pak4, which is genetically dispensable for development, despite a morphant phenotype that can be rescued by mRNA injection (Law and Sargent, 2014) . Given the high copy number of injected MO (10 ng of a MO is equal to approximately 6.3×10 11 molecules), as well as the rescue RNA, which is typically co-injected, it is possible that non-specific interference of the co-injected RNA with the MO may lead to reduced knockdown efficiency and apparent rescue. Most studies also fail to confirm that endogenous protein or transcript is similarly affected by MO injection in both the absence and presence of rescue mRNA. Thus, current methods of rescue for morphant phenotypes are not a reliable guideline for verification of MO specificity.
MO off-target effects have been attributed to p53 induction that leads to apoptosis (Robu et al., 2007) and can cause seemingly specific gene expression changes in certain cell types (Amoyel et al., 2005; Gerety and Wilkinson, 2011) . However, little is known concerning the mechanism by which MOs induce p53 activation. While characteristics of the MO backbone are thought to reduce interactions with macromolecules, there are only anecdotal claims to this effect (Summerton, 2007) and no studies have investigated off-target effects independent of RNA binding. Furthermore, MOs bearing up to 4 base mismatches can effectively inhibit target mRNA, suggesting a wide spectrum of off-target RNA binding. Thus, more global effects on translation, splicing, and, possibly, small RNA processing are possible. This, in turn, could trigger the induction of p53. In this case, p53 knockdown would only ameliorate some of the observed off-target effects. Notably, a recent study demonstrates that a morphant phenotype not rescued by p53 knockdown, and therefore thought to be specifically caused by knockdown of the target gene, was also not seen in the corresponding null maternal/zygotic mutant (Law and Sargent, 2014) . Thus, similar to mRNA injection, p53 knockdown may not be a reliable indicator for the specificity of a morphant phenotype. If MOs are to be applied as a tool in parallel with targeted gene knockout to discern gene function, further studies are clearly needed to clarify the mechanism of off-target responses.
The ability to knock down candidate genes of interest using MOs clearly had an impactful role in the application of the zebrafish as a model system. Indeed, nearly 300 morphant phenotypes curated in ZFIN are consistent with those observed in mutant embryos (unpublished observation), as are several in the current study. However, there have long been anecdotal claims within the zebrafish community of problematic p53-independent offtarget effects and variability due to different preparations of the same MO. Based on these reports, Drs. Judith Eisen and James Smith published a list of guidelines for the reliable application of MOs in frog and zebrafish in 2008 (Eisen and Smith, 2008) . Among their recommendations was that, whenever possible, investigators confirm a morphant phenotype by comparison to a mutant, if available. Our findings here suggest that this is the most essential guideline to follow. At the same time, it is also important to validate the characteristics of newly generated mutant lines in parallel to confirm their effect on candidate gene function. Indeed, we noted cases of exon skipping and splicing defects in some mutants. Moving forward, we recommend targeting exons encoding domains that are necessary for protein function or generating segmental deletions. Given the ease of use of current site-specific nuclease technologies, most notably the CRISPR systems, we would advocate for widespread application of these approaches to generate mutants. While this approach requires a significant research investment (typically between 6 to 12 months from initial injections to phenotypic characterization of mutant phenotypes), our observations clearly demonstrate the need for a genetic approach as the definitive determination of gene function. Moreover, we would suggest broader community-wide and editorial guidelines that require an observed MO-induced phenotype to be validated in embryos bearing mutations in the same gene, after which a MO could then be reliably applied for subsequent functional studies.
EXPERIMENTAL PROCEDURES Zebrafish Handling and Maintenance
Zebrafish were maintained in accordance with approved institutional protocols at the University of Massachusetts Medical School and the Hubrecht Institute. The Tg(fli1a:egfp) y1 , Tg(kdrl:egfp) s843 , Tg(gata1a:dsRed) sd2 , Tg(flt4:mCitrine) hu7135 , and Tg(flt1:tdTomato) hu5333 transgenic lines have been described elsewhere (Beis et al., 2005; Bussmann et al., 2010; Lawson and Weinstein, 2002; Traver et al., 2003; van Impel et al., 2014) .
Construction of site-specific nucleases
Zinc finger nucleases (ZFNs) or TAL effector nucleases (TALENs) were constructed as described elsewhere (Kok et al., 2014) . Appropriate zinc finger cassettes and target sites were identified in candidate genes using previously described databases of targets identified in the zebrafish genome (Gupta et al., 2012; Zhu et al., 2011) . TALEN sequences were identified in candidate genes using TAL effector Nucleotide Targeter 2.0 (https://talent.cac.cornell.edu/). The list of target sites within candidate genes can be found in Table S2 . All nuclease sequences are available upon request. Generation of mutant lines was performed as described elsewhere (Kok et al., 2014; Meng et al., 2008; Gupta et al., 2013) . A sgRNA targeting ets1 (Table S2 ) was chosen based on location in a functional domain and presence of restriction enzyme site useful for genotyping. sgRNA was synthesized and used to generate mutant founders based on published protocols (Gagnon et al., 2014) .
Phenotypic analysis
Embryos derived from identified heterozygous carriers were observed every day for the first 5 days of development using a dissection microscope. Transmitted light and DIC images, as well as analysis of vascular or lymphatic morphology using confocal or 2-photon microscopy were performed as described elsewhere (Quillien et al., 2014; van Impel et al., 2014) . In some cases, transgenic embryos were fixed and subjected to immunostaining with GFP antibody to boost the fluorescent signal, as we have done previously (Covassin et al., 2006) . All embryos were subsequently subjected to individual genotypic analysis, which was performed using restriction digest of PCR fragments encompassing the targeted sequence as we have done previously (Meng et al., 2008) .
RT-PCR and Western blot analysis.-We performed RT-PCR or Western blot analysis on wild type and mutant sibling embryos as follows: individual embryos were anesthetized according to standard protocols, their heads were removed using a scalpel, and transferred to an individual well of a 96-well plate. In parallel, the trunk region was transferred to individual Eppendorf tubes in a dry ice/ethanol bath and subsequently stored at −80°C. Embryo heads were used for genomic DNA isolation and genotype analysis as described previously (Meng et al., 2008) . Several trunks of genotypically identical embryos were pooled and dissociated in Trizol, or lysed in sample buffer for protein isolation. Reverse transcription of total RNA was performed using oligo-dT and Superscript III (Invitrogen) according to manufacturer's protocols. PCR was performed using primers listed in Supplemental Experimental Procedures. PCR fragments from genomic DNA were directly sequenced, while those from cDNA were cloned into pGEM-T (Promega) prior to sequencing. Western blot analysis was performed according to standard protocols. An antibody against zebrafish Pdgfrb was raised in rabbits (Innovagen, Lund, Sweden) using a synthetic peptide (KYADIQPSPYESPYQQDIYQ).
Riboprobes-Fragments for synthesizing riboprobes were amplified from wild type cDNA and cloned into pGEM-T by TA cloning (Promega). Oligonucleotide primers are listed in Supplemental Experimental Procedures. To generate digoxigenin labeled antisense riboprobes, DNA templates were first generated from plasmids using M13 forward and reverse primers. Templates were purified by ethanol precipitation and used for in vitro transcription using the appropriate bacteriophage RNA polymerase. The riboprobe against pdgfrb was prepared by linearizing the template plasmid with Apa I prior to synthesis with RNA polymerase.
Integration of Sanger and ZFIN datasets-
We downloaded the list of phenotyped mutants generated through the Sanger Zebrafish Mutation resource from the Sanger Center website (http://www.sanger.ac.uk/sanger/Zebrafish_Zmpbrowse). We downloaded and extracted all morphant data from the Zebrafish Information Network (http://zfin.org/ downloads/phenoGeneCleanData.txt). Both downloads were done in April 2014. Datasets were cross-referenced to identify genes for which MO-mediated knockdown resulted in a phenotype and a corresponding mutant had been subjected to phenotypic analysis (98 genes). We next restricted analysis to only whole embryos phenotypes, (Field = "_Affected_structure_or_Process_1_superterm_Name", term = "whole organism"), yielding 33 genes. This list was subsequently hand annotated through primary literatures searches to confirm that curated ZFIN data was accurate. From this analysis, we eliminated 4 genes that gave subtle morphant phenotypes, and 1 gene that did not recapitulate the phenotype of a previously existing mutant. We further removed 4 genes that were less likely to bear severely mutagenic alleles (Table S4 ). To assess maternal contribution, we integrated published RNA-Seq data and verified application of translation or splice blocking MOs from the primary literature in each case. We also took into account other published sources investigating genetic maternal requirement, including our observations in this study. Genes for which fragments per kilobase per million (FPKM) was 0, or which displayed a phenotype with a splice-blocking MO, were classified as "unlikely" to contribute maternal function. All others were classified as "possible".
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